Congenica COVID-19 is a module within the Congenica Clinical Decision Support platform containing expert curated gene panels relevant for SARS-CoV-2 infection to provide a solution for researchers to rapidly analyze the genetic contribution to COVID-19 response and the biological pathways involved.
Copyright © 2022 Congenica Ltd, Company number: 8273616 Registered in England and Wales
Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory.